Clinical Trial Update: Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating octreotide for reducing blood loss and transfusion needs during laparoscopic hepatectomy in patients with hepatic carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Carcinoma
• Hepatic Metastasis

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Hepatic Carcinoma, Hepatic Metastasis | Phase 2 | Status: UNKNOWN